Quote:
Originally Posted by ianch99
|
It wasn't about whether the vaccine development would be allowed.
So the comment from the EU is nonsense.
Link
Quote:
|
In his letter, Sir Tim said the UK would not participate because the "UK would be required to stop its negotiations with manufacturers with which the EU launched negotiations".He said the commission had also confirmed it was "not possible for the UK to have a role in the governance shaping decisions on which manufacturers to negotiate with, or the price, volume and delivery schedule negotiated".
|
We WOULDN'T have been allowed to independently negotiate with ANY vaccine suppliers. It would be only the EU allowed to do that. Theoretically even the likes of Germany and France wouldn't be allowed to
independently negotiate anything.
From the actual letter.
Quote:
|
We are committed to building on this shared endeavour and believe there are other areas where we should look to strengthen our collaboration. This could include sharing of information on promising vaccine candidates; negotiations with vaccine manufacturers; vaccine trials; manufacturing investment and capacity building; mitigations to supply chain bottlenecks and other delivery risks such as global trade disruptions.
|
So we're NOT ignoring the EU completely.
Official EU Press release
Quote:
|
In order to support companies in the swift development and production of a vaccine, the Commission will enter into agreements with individual vaccine producers on behalf of the Member States. In return for the right to buy a specified number of vaccine doses in a given timeframe, the Commission will finance part of the upfront costs faced by vaccines producers.
|
Quote:
|
Securing the production of vaccines in the EU and sufficient supplies for its Member States through Advance Purchase Agreements with vaccine producers via the Emergency Support Instrument. Additional financing and other forms of support can be made available on top of such agreements.
|
We already have supply deals in place.
Eg
Quote:
Meanwhile, Oxford University signed a global licensing agreement with AstraZeneca for the manufacturing and commercialisation of their vaccine candidate. If the vaccine is successful, AstraZeneca will produce up to 30 million doses by September for people in the UK.
The agreement is for the pharmaceutical company to deliver a total of 100 million doses.
Business Secretary Alok Sharma said: “Our scientists are at the forefront of vaccine development. This deal with AstraZeneca means that if the Oxford University vaccine works, people in the UK will get the first access to it, helping to protect thousands of lives.
|
The UKs deal was in place a month before the EUs.
Link
Quote:
|
AstraZeneca has reached an agreement with Europe’s Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France, Italy and the Netherlands, to supply up to 400 million doses of the University of Oxford’s COVID-19 vaccine, with deliveries starting by the end of 2020.
|
So the UK deal is an initial 30m doses by September and the EU one is starting by the end of this year. Which is better?
We're ahead of the EU in making the deals, why would we surrender those deals?
Link
Quote:
|
Mr Hancock confirmed the UK was already putting in contracts with vaccine developers around the world, and was engaging will all 10 of the development projects regarded as the frontrunners, including those at Oxford University and Imperial College London.
|